Ticagrelor in stable coronary disease
- PMID: 37586825
- DOI: 10.1136/heartjnl-2023-323034
Ticagrelor in stable coronary disease
Keywords: Atherosclerosis; Coronary Stenosis.
Conflict of interest statement
Competing interests: NPJ receives internal funding from the Weatherhead PET Center for Preventing and Reversing Atherosclerosis; significant institutional research support from Neovasc/Shockwave (PET core lab for COSIRA-II, NCT05102019) and CoreAalst (PPG Global, NCT04789317); institutional licensing agreement with Boston Scientific for the smart minimum FFR algorithm commercialised under 510(k) K191008; and patents pending on diagnostic methods for quantifying aortic stenosis and TAVI physiology, and on methods to correct pressure tracings from fluid-filled catheters.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical